Controversies in the definition and treatment of idiopathic short stature (ISS).

Stefania Pedicelli, Emanuela Peschiaroli, Enrica Violi, Stefano Cianfarani

Research output: Contribution to journalArticlepeer-review

Abstract

The term idiopathic short stature (ISS) refers to short children with no identifiable disorder of the growth hormone (GH)/insulin like growth factor (IGF) axis and no other endocrine, genetic or organ system disorder. This heterogeneous group of short children without GH deficiency (GHD) includes children with constitutional delay of growth and puberty, familial short stature, or both, as well as those with subtle cartilage and bone dysplasias. In rare cases, ISS is due to IGF molecular abnormalities. In this review we tackle the major challenges in the definition and treatment of ISS.

Original languageEnglish
Pages (from-to)105-115
Number of pages11
JournalJournal of clinical research in pediatric endocrinology
Volume1
Issue number3
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Controversies in the definition and treatment of idiopathic short stature (ISS).'. Together they form a unique fingerprint.

Cite this